Stock screenerAll disclosures →
EDGAR →
AVTX
SetupConviction 63LongHealthcareScan · Mon, Aug 10, 2026Flat basebase
AVTX$19.76+7.86%
ResistanceSupportVol 14Insider sellVol MA14 985.52K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Trade plan
LongReward : Risk0.89Entry
Entry
20.01
Risk
Stop
17.22
-14.0% to stop
Reward
Target 1
22.48
+12.3% to target
Stretch
Target 2
24.95
+24.7% to T2
Risk : reward balance
Risk to stopReward to target
Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.
Price19.76
Change+7.86%
Gap-1.09%
Rel volume4.00×
Avg volume979.95K
Avg $ vol18.48M
SMA 2018.67
SMA 5017.31
SMA 20016.62
Price vs 50+14.16%
Price vs 200+18.87%
MA stackbullish
50/200 cross—
Supertrendup · 15.85
RSI (14)58
MACD hist-0.05
MACD cross—
Stoch %K / %D90 / 56
ADX (14)22
+DI / −DI23 / 11
RSI divergenceBearish
MACD divergence—
ATR %+6.49%
ADR %6.44%
52w high22.87
52w low8.90
From 52w high-13.60%
Above 52w low+122.15%
New 52w highNo
SqueezeOn · 11d
Bollinger width12.25%
%B0.97
Donchian pos89.88%
Donchian high20.01
Donchian low17.54
AVWAP (52w high)17.66
vs AVWAP high+11.91%
AVWAP (52w low)16.96
vs AVWAP low+16.51%
OBV trendUp
Chaikin MF (20)0.09
Today vs 20d4.00×
Avg vol (14d)985.52K
Avg vol (20d)979.95K
Avg $ vol (20d)18.48M
Market cap—
RS 3m (vs SPY)-25.59%
RS 6m (vs SPY)+25.20%
RS line new highNo
Trend template5/8
Technical rank84.0
1 week+9.47%
1 month+2.86%
3 months-8.39%
6 months+39.25%
1 year+136.65%
YTD+16.10%
P/E-12.57
P/B2.19
P/S—
P/FCF-19.08
EPS-5.84
Div yield—
ROE-17.44%
ROA-15.95%
Debt/Eq0.03
Current19.31
EV/EBITDA-12.59
Gross margin—
Net margin—
Rev growth-86.62%
EPS growth-122.78%
Price target44.20
Target upside141.00%
Analyst ratingBuy
Institutional73.66%
Ent. value913.5M
Revenue0
Net income-36.36M
Gross profit—
Free cash flow-51.55M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out52.57M
Employees33
ListedFri, Nov 13, 2015
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction63 / 100
Pattern quality71%
Tech rank84.0 / 100
Group rank86 / 100 · Leading
Status laneSetting up
Setup directionLong
Pattern familyBase
Resistance20.01
Support17.54
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in AVTX
No recent disclosed trades by Congress in AVTX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in AVTX · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Doyle Mittie Chief Medical Officer · Common Stock · 2026-06-23 | Sell | 1.45K | $26K | 2026-06-23 | 2026-06-25 |
Doyle Mittie Chief Medical Officer · Common Stock · 2026-06-23 | Exercise | 1.45K | $12K | 2026-06-23 | 2026-06-25 |
Doyle Mittie Chief Medical Officer · Stock Option (Right to Buy) · 2026-06-23 | Exercise | 1.45K | — | 2026-06-23 | 2026-06-25 |
Philip Ron M Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 40.2K | — | 2026-06-23 | 2026-06-25 |
VARKI PAUL Chief Legal Officer · Common Stock · 2026-06-10 | Tax | 1.08K | $14K | 2026-06-10 | 2026-06-12 |
Sullivan Christopher Ryan Chief Financial Officer · Common Stock · 2026-06-10 | Tax | 138 | $2K | 2026-06-10 | 2026-06-12 |
Doyle Mittie Chief Medical Officer · Common Stock · 2026-06-10 | Tax | 1.08K | $14K | 2026-06-10 | 2026-06-12 |
Riley Jennifer Chief Strategy Officer · Common Stock · 2026-06-10 | Tax | 588 | $8K | 2026-06-10 | 2026-06-12 |
Jain Rita Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 20.1K | $0 | 2026-06-02 | 2026-06-04 |
KANTOFF AARON Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 20.1K | $0 | 2026-06-02 | 2026-06-04 |
SEC filings
EDGAR filings in AVTX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.